Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pollock

Showing results (861-870 of 896) with videos related to

Pageof 90
Sort By:
Theranostics|February 28, 2020
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancerBrittney S Harrington, Yaowu He, Tashbib Khan, et al.
Cancer Cell|July 12, 2011
Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitorScott R Daigle, Edward J Olhava, Carly A Therkelsen, et al.
Genome Medicine|January 11, 2022
Patient-derived xenograft models capture genomic heterogeneity in endometrial cancerVanessa F Bonazzi, Olga Kondrashova, Deborah Smith, et al.
European Journal of Human Genetics : EJHG|June 17, 2021
ADAMTS1, MPDZ, MVD, and SEZ6: candidate genes for autosomal recessive nonsyndromic hearing impairmentThashi Bharadwaj, Isabelle Schrauwen, Sakina Rehman, et al.
American Journal of Human Genetics|June 4, 2016
A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 BindingJodie N Painter, Susanne Kaufmann, Tracy A O'Mara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2020
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant TherapyAlicia León-Castillo, Stephanie M de Boer, Melanie E Powell, et al.
The Lancet. Infectious Diseases|April 14, 2024
An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trialKatrina M Pollock, Álvaro H Borges, Hannah M Cheeseman, et al.
AJNR. American Journal of Neuroradiology|June 13, 2020
Distinguishing Extravascular from Intravascular Ferumoxytol Pools within the Brain: Proof of Concept in Patients with Treated GlioblastomaR F Barajas, D Schwartz, H L McConnell, et al.
Elife|January 23, 2014
Extinction risk and conservation of the world's sharks and raysNicholas K Dulvy, Sarah L Fowler, John A Musick, et al.
Molecular Cancer Therapeutics|February 25, 2014
Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphomaSarah K Knutson, Satoshi Kawano, Yukinori Minoshima, et al.
Pageof 90

Showing results (861-870 of 896) with videos related to

Sort By:
Pageof 90
Theranostics|February 28, 2020
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancerBrittney S Harrington, Yaowu He, Tashbib Khan, et al.
Cancer Cell|July 12, 2011
Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitorScott R Daigle, Edward J Olhava, Carly A Therkelsen, et al.
Genome Medicine|January 11, 2022
Patient-derived xenograft models capture genomic heterogeneity in endometrial cancerVanessa F Bonazzi, Olga Kondrashova, Deborah Smith, et al.
European Journal of Human Genetics : EJHG|June 17, 2021
ADAMTS1, MPDZ, MVD, and SEZ6: candidate genes for autosomal recessive nonsyndromic hearing impairmentThashi Bharadwaj, Isabelle Schrauwen, Sakina Rehman, et al.
American Journal of Human Genetics|June 4, 2016
A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 BindingJodie N Painter, Susanne Kaufmann, Tracy A O'Mara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2020
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant TherapyAlicia León-Castillo, Stephanie M de Boer, Melanie E Powell, et al.
The Lancet. Infectious Diseases|April 14, 2024
An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trialKatrina M Pollock, Álvaro H Borges, Hannah M Cheeseman, et al.
AJNR. American Journal of Neuroradiology|June 13, 2020
Distinguishing Extravascular from Intravascular Ferumoxytol Pools within the Brain: Proof of Concept in Patients with Treated GlioblastomaR F Barajas, D Schwartz, H L McConnell, et al.
Elife|January 23, 2014
Extinction risk and conservation of the world's sharks and raysNicholas K Dulvy, Sarah L Fowler, John A Musick, et al.
Molecular Cancer Therapeutics|February 25, 2014
Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphomaSarah K Knutson, Satoshi Kawano, Yukinori Minoshima, et al.
Pageof 90